Craig Daniel Seaman MD

Clotting Disorder, Hemophilia & Bleeding Disorder

Assistant Professor of Medicine

3636 Boulevard of the AlliesPittsburgh, PA 15213
Phone+1 412-209-7280

Dr. Seaman is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Seaman's full profile Already have an account?

Education & Training

UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2011 - 2014
UPMC Medical EducationResidency, Internal Medicine, 2008 - 2011
Marshall University Joan C. Edwards School of MedicineClass of 2008

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

PA State Medical License 2008 - 2026
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2015-2016
CMS Meaningful Use Stage 1 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2015-2016

Clinical Trials

Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome
TERMINATED
PHASE2
Weight-based Dosing in Hemophilia A
TERMINATED
PHASE2

Publications & Presentations

PubMed

Impact of tranexamic acid on postpartum hemorrhage in type 1 von Willebrand disease treated with recombinant VWF.
Nicoletta C Machin, Maria M Brooks, Deborah Vehec, Dana Ivanco, Brandon Lawryk
Blood Advances. 2025-12-09
2 citations
Efficacy of adjusted weight-based dosing of desmopressin (1-deamino-8-d-arginine vasopressin in type 1 von Willebrand disease.
Craig D Seaman
Blood Coagulation & Fibrinolysis. 2023-10-01
26 citations
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a pha...
Margaret V Ragni, Scott D Rothenberger, Robert Feldman, Danielle Nance, Andrew D Leavitt
The Lancet. Haematology. 2023-08-01

Abstracts/Posters

Emicizumab Prophylaxis in Patients with Hemophilia _ with and without Inhibitors
Craig D. Seaman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial
Craig D. Seaman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019